Yan Piskunov

Kimba’s technology uses AI to analyze biometric data and offer a personalized scent therapy to improve sleep and health.

Scala Biodesign stands at the forefront of the current revolution in protein design. Scala’s no-code one-shot software enables R&D teams to design their proteins in a single design cycle, increasing success rates, reducing R&D effort, and accelerating time-to-market. Scalas technologies, developed by its founding team at the Weizmann Institute of Science, are backed by an unprecedented record of over 130 peer-reviewed publications and collaborations with 80 commercial and academic partners. This includes the first-ever one-shot design of a malaria vaccine candidate, now advancing through Phase II clinical trials, and proteins that were previously considered out of reach across biotherapeutics, enzymes for biomanufacturing, diagnostics, and other bio-based products. Utilizing this unique edge, Scala aims to disrupt the field and democratize the way proteins are developed. Scala has already partnered with five of the top-20 pharmaceutical companies and other market leaders across multiple verticals.

Hud addresses a key gap in AI agentic coding and software engineering: building code that actually works in complex, real-world production environments at scale. Our Runtime Code Sensor installs in under a minute, with zero configuration or maintenance required. It automatically captures live service and function-level data from production- providing the missing context to detect and fix issues, and to build production-safe features.

Anchor gets businesses paid on time, effortlessly. Anchor’s autonomous billing solution is a cloud-based platform that redefines B2B billing, collections, and payments. By providing an end-to-end billing and collections solution, and removing all manual labor from these processes, Anchor eliminates the risks of fraud and human error in B2B payments. Founded in 2021, Anchor is a U.S. company, with an R&D Center in Israel. Backed by market leaders including Rapyd Ventures, Entrée Capital, Tal Ventures, and additional CEOs and founders from the tech and finance space, Anchor brings the SaaS billing experience to the B2B service industry and is the first to support dynamic billing needs that change constantly. Anchor’s purpose is to make business owners thrive, by allowing them to focus their time and resources on doing business, not billing. Visit www.sayanchor.com to learn more and get started.

Chemical technology platform to make sustainable aviation fuel (SAF), renewable gasoline, renewable LPG, renewable chemicals (BTX).

SWAPP’s platform automates the most cumbersome and error-prone architectural planning phase: the production of construction documents (CD). SWAPP clients benefit from completing multiple projects simultaneously at a high speed and focusing more on creative planning and less on tedious repetitive manual labor. By combining algorithms, human expertise and end-to-end customer support, firms using SWAPP are reaching unprecedented goals and significantly increase both their gross margin and productivity. Learn more about us on our website >> www.swapp.ai

Remepy is Pioneering Hybrid Drugs™. Many medical conditions are better treated by combining pharmaceutical and non-pharmaceutical treatments. Hybrid drugs are a new type of drug asset, that combines traditional drugs with proprietary treatment protocols delivered measured and adapted using our AI capabilities. Remepy’s Digital Molecules™ are designed to be the software apps within Hybrid Drugs™. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its corresponding drug and are constantly measured and tracked and personalized using advanced AI capabilities. The Digital Molecules™ enhance brain functions that balance the patients neuro-endocrine and neuro-immunological systems and boost brain neuroplasticity, in order to optimize drug performance. We also address physical, motor, psychological, and behavioral symptoms Remepy partners with pharma companies to bring Hybrid Drugs™ to market that will combine Remepy’s Digital Molecule™ and traditional drug components.

Sygnum is a global digital asset banking group, founded on Swiss and Singapore heritage. We empower professional and institutional investors, banks, corporates and DLT foundations to invest in digital assets with complete trust. Our team enables this through our institutional-grade security, expert personal service and portfolio of regulated digital asset banking, asset management, tokenisation and B2B services. Sygnum Bank AG (CH) holds a banking licence and is regulated in the financial hubs of Abu Dhabi and Luxembourg. Sygnum PTE Ltd. (SG) and Sygnum Europe AG (LI) have obtained a financial services license or registration. We believe that the future has heritage. Our crypto-native team of banking, investment and digital asset technology professionals are building a trusted gateway between the traditional & digital asset economies that we call Future Finance. Statements and posts via this channel contain general information about Sygnum and are not intended to address a specific market. Communications Sygnum will never post messages in social media networks or private messaging apps that provide investment advice or ask to login to your account, change your password, make deposits, transfer funds or make any other financial transactions. There are individuals who may attempt to impersonate trusted organisations to get access to your information and financial assets. Sygnum urges you to stay alert to potentially fraudulent emails, calls, SMS’s and content on messaging and social networks that pretend to represent Sygnum, our staff, advisors and partners. We only publish Sygnum content via www.sygnum.com, our LinkedIn channel (this profile), and on X via @sygnumofficial. Contact us If you come across unsolicited messages related to Sygnum, please do not reply or open any electronic files or click on any links and report them immediately to security@sygnum.com

Bondaval combines world-class software engineering with powerful insurance cover to create intelligent credit risk protection. With reminders, tools and alerts tailored to each exact policy, Bondaval products helps companies to effortlessly protect their bottom line, while unlocking insights on customer payment behaviour and credit worthiness. Got questions? Send us a Linkedin message 👋

Solidus Labs detect and deter security and compliance risks throughout the digital asset lifecycle. Explore our crypto-native Trade Surveillance, Transaction Monitoring, and Staking Guard solutions today

Daisy is a tech-driven, full-service condo and co-op management company, reimagining how buildings are run. Boards govern easily, neighbors live better, and home feels like home.

Our mission is to keep small business in business. When we started Melio, we wanted to build more than an efficient Accounts Payable tool. We wanted to build a service that helps small businesses keep up with business. A B2B payments experience that not only saves time but also significantly improves cash flow. A payment workflow so simple it helps businesses focus on their customers, not their back office.

Empathy is a leading technology company transforming the way people plan for and navigate life’s toughest moments. By combining cutting-edge innovation with compassion, Empathy provides unparalleled support for bereavement, estate management, legacy planning, and more. Trusted by Fortune 500 companies and leading life insurers, Empathy serves over 40 million individuals across North America, setting a new standard for modern family care and workplace benefits. Empathy’s mission is to make care as practical as it is compassionate—partnering with employers, insurers, and financial institutions to deliver scalable support that eases emotional burdens, simplifies complex logistics, and empowers families to move forward with clarity and resilience.

Billions of people want to move countries, and 100s of millions of people do - but when they do they are locked out or overcharged for the financial products most people take for granted. Since 2017 weve set out to change that. Since then we have served millions of migrants by giving them cheaper insurance and access to credit. And, weve only just got started - we have so many more products to build and customers to service. We believe to be continually successful we need to attract the best people. So far we have 700+ people across 3 countries, and we are always on the look-out for more brilliant people. People who are ambitious, smart, collaborative, and get things done. Want to join us on our mission? Check out our live roles on Linkedin by clicking the jobs tab (see above ☝️) and on our careers page: https://www.marshmallow.com/jobs

The $500 billion global freight market that transports nearly everything we eat, wear and use around the world remains almost completely offline. Which means that our everyday products cost more than they should. Freightos® makes international shipments faster, more cost-effective and reliable, expanding global trade between the people of the world with the largest global digital freight booking platform. Using a combination of breakthrough technology, data, and a platform that spans multiple global logistics providers, importers, airlines, ocean liners, and leading tech players, Freightos includes Freightos Marketplace, WebCargo, WebCargo for Airlines, Clearit and Freightos Enterprise, including Freightos market intelligence module, Terminal. Together, this ecosystem makes global trade smoother and more frictionless.

Kimba’s technology uses AI to analyze biometric data and offer a personalized scent therapy to improve sleep and health.

Scala Biodesign stands at the forefront of the current revolution in protein design. Scala’s no-code one-shot software enables R&D teams to design their proteins in a single design cycle, increasing success rates, reducing R&D effort, and accelerating time-to-market. Scalas technologies, developed by its founding team at the Weizmann Institute of Science, are backed by an unprecedented record of over 130 peer-reviewed publications and collaborations with 80 commercial and academic partners. This includes the first-ever one-shot design of a malaria vaccine candidate, now advancing through Phase II clinical trials, and proteins that were previously considered out of reach across biotherapeutics, enzymes for biomanufacturing, diagnostics, and other bio-based products. Utilizing this unique edge, Scala aims to disrupt the field and democratize the way proteins are developed. Scala has already partnered with five of the top-20 pharmaceutical companies and other market leaders across multiple verticals.

Hud addresses a key gap in AI agentic coding and software engineering: building code that actually works in complex, real-world production environments at scale. Our Runtime Code Sensor installs in under a minute, with zero configuration or maintenance required. It automatically captures live service and function-level data from production- providing the missing context to detect and fix issues, and to build production-safe features.

Anchor gets businesses paid on time, effortlessly. Anchor’s autonomous billing solution is a cloud-based platform that redefines B2B billing, collections, and payments. By providing an end-to-end billing and collections solution, and removing all manual labor from these processes, Anchor eliminates the risks of fraud and human error in B2B payments. Founded in 2021, Anchor is a U.S. company, with an R&D Center in Israel. Backed by market leaders including Rapyd Ventures, Entrée Capital, Tal Ventures, and additional CEOs and founders from the tech and finance space, Anchor brings the SaaS billing experience to the B2B service industry and is the first to support dynamic billing needs that change constantly. Anchor’s purpose is to make business owners thrive, by allowing them to focus their time and resources on doing business, not billing. Visit www.sayanchor.com to learn more and get started.

Chemical technology platform to make sustainable aviation fuel (SAF), renewable gasoline, renewable LPG, renewable chemicals (BTX).